0001450324-19-000005.txt : 20190130 0001450324-19-000005.hdr.sgml : 20190130 20190130113637 ACCESSION NUMBER: 0001450324-19-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190128 FILED AS OF DATE: 20190130 DATE AS OF CHANGE: 20190130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STRAYER DAVID R CENTRAL INDEX KEY: 0001270074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 19550871 MAIL ADDRESS: STREET 1: 600 MAIN STREET STREET 2: SUITE 2 CITY: RIVERTON STATE: NJ ZIP: 08077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 BUSINESS PHONE: 215-988-0080 MAIL ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-01-28 0 0000946644 HEMISPHERX BIOPHARMA INC HEB 0001270074 STRAYER DAVID R 600 MAIN STREET SUITE 2 RIVERTON NJ 08077 0 1 0 0 Chief Science/Medical Officer Options to buy Common Stock 0.22 2019-01-28 4 A 0 184659 0 A 2019-01-28 2029-01-28 Common Stock 184659 184659 D This option is being issued to senior management for a voluntary 50% deferral in salary. David R. Strayer 2019-01-30